Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY-NC-NDTumour Virus Research

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL

Abstract

Human T-cell Leukemia Virus type 1 (HTLV-1) drives Adult T-cell Leukemia/Lymphoma (ATLL) through sustained expression of the viral oncoprotein HBZ. Although HBZ is known to reshape host transcriptional programs, its role in post-transcriptional regulation in ATLL remains poorly understood. Here, we uncover a mechanism by which HBZ reprograms circular RNA (circRNA) biogenesis to support leukemic cell survival. Comprehensive circRNA profiling across ATLL subtypes revealed extensive circRNA remodeling, with distinct signatures associated with aggressive ATLL subtypes. Among these, circAFF2(3) is markedly upregulated in aggressive ATLL, and functional analyses show that its expression enhances, whereas its silencing reduces, the survival of HTLV-1-transformed T cells. Mechanistically, we show that HBZ interacts with the RNA helicase DHX9 and inhibits its helicase activity at intronic double-stranded RNA structures flanking circularized exons. Using both endogenous and synthetic circRNAs, we demonstrate that this inhibition allows RNA duplexes to persist, thereby promoting back-splicing and the accumulation of DHX9-sensitive circRNAs, including circAFF2(3). Together, these findings reveal that HTLV-1 hijacks host RNA helicase activity to reprogram circRNA biogenesis, identifying the HBZ-DHX9 axis as a novel post-transcriptional mechanism contributing to ATLL development.

Related

  1. Comprehensive circRNA Profiling Reveals a Testis-Specific circRNA circdmrt1 as a Novel Regulator of Gonadal Development in Crucian Carp
    Dongmei Zhong, Faxiang Li, Ziyu Yang +10
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. A false sense of circularity: hidden variability in RNase R enzymes confounds reliable circRNA validation
    L. Ulrix, J. H. De Waele, J. Vandesompele +3
    bioRxivPreprintCC BY-NDFull textMolecular biology & gene regulationbioRxiv
  3. CPRISP: an interpretable deep learning framework predicting circRNA-RBP interactions and guiding therapeutic discovery in neurodegeneration
    Yongtian Wang, Jiahao Li, Xinmeng Liu +2
    Nature CommunicationsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  4. Exosomal CircRNA_102619–miR-330-3p Interaction Regulates Osteosarcoma Progression and Metastasis by Forming the Lung Pre-Metastatic Niche
    Ming-Yu Lien, Yu-Hsiang Chang, Hsiao-Chi Tsai +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  5. A circRNA-microRNA-Pdcd1 axis drives microglial activation and retinal ganglion cell degeneration
    Lanfang Sun, Xiaoyu Ke, Jingjing Yu +14
    Communications BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{ladet2026htlv1,
  title = {{HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL}},
  author = {Julien Ladet and Mateo Bazire and Nicolas Fontrodona and Anne van den Broeke and Ambroise Marçais and Mariam Shallak and Greta Forlani and Roberto Accolla and Cyril Bourgeois and Franck Mortreux},
  journal = {Tumour Virus Research},
  year = {2026},
  month = jul,
  doi = {10.1016/j.tvr.2026.200347},
  url = {https://hal.science/hal-05787429v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL
AU  - Julien Ladet
AU  - Mateo Bazire
AU  - Nicolas Fontrodona
AU  - Anne van den Broeke
AU  - Ambroise Marçais
AU  - Mariam Shallak
AU  - Greta Forlani
AU  - Roberto Accolla
AU  - Cyril Bourgeois
AU  - Franck Mortreux
PY  - 2026
DA  - 2026/07/14
JO  - Tumour Virus Research
DO  - 10.1016/j.tvr.2026.200347
UR  - https://hal.science/hal-05787429v1
AB  - Human T-cell Leukemia Virus type 1 (HTLV-1) drives Adult T-cell Leukemia/Lymphoma (ATLL) through sustained expression of the viral oncoprotein HBZ. Although HBZ is known to reshape host transcriptional programs, its role in post-transcriptional regulation in ATLL remains poorly understood. Here, we uncover a mechanism by which HBZ reprograms circular RNA (circRNA) biogenesis to support leukemic cell survival. Comprehensive circRNA profiling across ATLL subtypes revealed extensive circRNA remodeling, with distinct signatures associated with aggressive ATLL subtypes. Among these, circAFF2(3) is markedly upregulated in aggressive ATLL, and functional analyses show that its expression enhances, whereas its silencing reduces, the survival of HTLV-1-transformed T cells. Mechanistically, we show that HBZ interacts with the RNA helicase DHX9 and inhibits its helicase activity at intronic double-stranded RNA structures flanking circularized exons. Using both endogenous and synthetic circRNAs, we demonstrate that this inhibition allows RNA duplexes to persist, thereby promoting back-splicing and the accumulation of DHX9-sensitive circRNAs, including circAFF2(3). Together, these findings reveal that HTLV-1 hijacks host RNA helicase activity to reprogram circRNA biogenesis, identifying the HBZ-DHX9 axis as a novel post-transcriptional mechanism contributing to ATLL development.
SN  - 2666-6790
ER  -